Article
Potential drug targets for asthma identified in the plasma and brain through Mendelian randomization analysis.
Frontiers in immunology - 1 Jan 2023
Wang Yuting, Wang Jiaxi, Yan Zhanfeng, Liu Siming, Xu Wenlong
Abstract excerpt
Background: Asthma is a heterogeneous disease, and the involvement of neurogenic inflammation is crucial in its development. The standardized treatments focus on alleviating symptoms. Despite the availability of medications for asthma, they have proven to be inadequate in controlling relapses and halting the progression of the disease. Therefore, there is a need for novel drug targets to prevent asthma. Methods:...
Topics
Join the communities discussing this publication.